| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Loss of energy | 6 | 2 | |
| Support immune health | 2 | 0 | |
| Chronic Epstein-Barr | 1 | 0 | |
| Myalgic encephalomyelitis/chronic fatigue syndrome | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 2 |